Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 51 | 0 | 4 | 0 | €686.90 | €759.34 | 10.545% |
| AbbVie Inc. | 21 | 0 | 3 | 0 | €151.56 | €174.43 | 15.092% |
| Amgen Inc. | 23 | 0 | 2 | 0 | €288.30 | €298.90 | 3.675% |
| Biogen Inc. | 45 | 2 | 2 | 0 | €202.90 | €294.01 | 44.904% |
| Incyte Corp. | 12 | 2 | 2 | 0 | €49.92 | €78.42 | 57.096% |
| Pfizer Inc. | 31 | 4 | 1 | 0 | €25.88 | €41.10 | 58.821% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 1 | 0 | €884.00 | €957.22 | 8.283% |
| Vertex Pharmaceuticals Inc. | 41 | 2 | 1 | 0 | €373.00 | €382.71 | 2.602% |
| Zoetis Inc. A | 21 | 1 | 1 | 0 | €156.40 | €200.06 | 27.914% |
| Novo Nordisk A/S ADR | 17 | 1 | 0 | 0 | €113.50 | €130.00 | 14.537% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €40.40 | - | - |
| Novartis AG ADR | 1 | 0 | 0 | 0 | €91.20 | - | - |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €124.20 | €130.00 | 4.670% |
| Exact Sciences | 11 | 0 | 0 | 0 | €57.68 | €83.49 | 44.755% |
| Sanofi S.A. ADR | 11 | 0 | 0 | 0 | €45.60 | - | - |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €140.25 | €165.00 | 17.647% |
| Bayer AG | 15 | 1 | 0 | 0 | €28.27 | €50.00 | 76.897% |
| Merck & Co. Inc. | 28 | 1 | 0 | 0 | €118.40 | €124.92 | 5.509% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Abbott Laboratories | 16 | 0 | 0 | 0 | €99.07 | €116.81 | 17.904% |
| UCB S.A. | 2 | 0 | 0 | 0 | €121.90 | - | - |
| Johnson & Johnson | 31 | 1 | 0 | 0 | €139.24 | €196.36 | 41.022% |
| GSK plc | 1 | 0 | 0 | 0 | €20.29 | - | - |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €114.80 | €109.00 | -5.052% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 0 | 0 | €76.62 | €102.62 | 33.932% |